An observational study in Sleep Apnoea and Cerebral Palsy, sponsored by University of Oulu. Completed at 1 site in Finland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-05-24.
Sponsored by University of Oulu · Observational
Obstructive sleep apnoea is a risk factor for ischaemic stroke. study hypothesis: In prospective study the investigators want to know how many ischaemic stroke patients have sleep apnoea and does thrombolysis play a role in severity of osa in six months follow up.
In prospective study the investigators include all over 18 years old patients who came to emergency room for ischaemic stroke. Exclusion criteria is not able to co-operate or need for intensive care unit.The investigators shall take 100 control patients who have ischaemic stroke and no thrombolysis and 100 study patients who will have thrombolysis. The investigators do sleep registration during hospital staying within 2 days after patients have felt ill.Follow-up registration will be done after 6 months at home.
1,422 studies on the registry are indexed under Apnea; 159 are open to participants now.
This study's enrollment of 256 is above the median of 106 across 386 observational studies indexed under Apnea.
Browse Apnea studies →University of Oulu is the lead sponsor of 138 studies on the registry; 21 are open to participants now.
Counted across the registry records on this site, refreshed daily.
residents of Oulu university hospital area. consecutive patient sampling
Exclusion Criteria:
We want to study the nasal-cpap treatment and it's compliance in sleep apnea patients with ischaemic stroke.
Device: Nasal CPAP
No nasal-cpap in sleep apnea patients with ischaemic stroke.
Nasal CPAP treatment for obstructive sleep apnoea
cerebral palsy events and severity of osa
in prospective study outcome measure is severity of osa in 6months follow-up
Time frame: from six months to twenty four months
Plan to share: Yes — Write a paper.
This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Oulu